✦ LIBER ✦

The ZEBRA study: Early benefits in quality of life in goserelin-treated vs CMF-treated pre-/perimenopausal patients with node-positive early breast cancer

✍ Scribed by M. Olschewski; H. de Haes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The ZEBRA study: Zoladex™ is as effectiv

✍ R. Blamey 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 257 KB

The ZEBRA study: Reversibility of bone m

✍ G.M. Blake; I. Fogelman 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Bone mineral density in premenopausal wo

✍ I. Fogelman; G.M. Blake; R. Blamey; M. Palmer; W. Sauerbrei; M. Schumacher; D. S 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 232 KB

P107 The ‘ZEBRA’ study: ‘Zoladex’ (goser

✍ W. Jonat; M. Kaufmann; R. Blamey; T. Sheldon 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Comparison of adjuvant endocrine treatme

✍ E. Kubista; M. Seifert; M. Gnant; R. Jakesz 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 163 KB

The influence of classical prognostic fa

✍ S Susnjar; I Kezic; Z Neskovic-Konstantinovic; D Gavrilovic; D Nikolic-Vukosavlj 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 319 KB